41-2
41st Parliament,
2nd Session
(October 16, 2013 - August 2, 2015)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
- Amir Attaran, Canadian Research Chair, Population Health and Global Development Policy, University of Ottawa (As an individual)
- Jack Corman, President (Institutional Review Board Services)
- Janet Currie, Representative (Psychiatric Medication Awareness Group)
- Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc. (Canadian Generic Pharmaceutical Association)
- Perry Eisenschmid, Chief Executive Officer (Canadian Pharmacists Association)
- Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services (Canadian Institute for Health Information)
- Matthew Herder, Assistant Professor, Health Law Institute, Faculties of Medicine and Law, Dalhousie University (As an individual)
- Ronald Heslegrave, Executive Director, William Osler Health System (As an individual)
- Dr. David Juurlink, Head, Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre (Institute for Clinical Evaluative Sciences)
- Brian O'Rourke, President and Chief Executive Officer (Canadian Agency for Drugs and Technologies in Health)
- Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network (Canadian Institutes of Health Research)
- Jared Rhines, Vice-president, Scientific and Strategic Affairs (Rx&D)
- Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis (HealthCareCAN (formerly ACAHO-CHA))
- Maureen Smith, Secretary (Canadian Organization for Rare Disorders)
- Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University (As an individual)
- Jennifer Zelmer, Executive Vice-President (Canada Health Infoway)
Meeting with Transcription and Interpretation